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One Sentence Summary: Oligomers of α-synuclein generate neuronal damage when insertion 
of a highly structured core causes disruption of membrane integrity. 
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Abstract: Oligomeric species populated during the aggregation process of α-synuclein have 
been linked to neuronal impairment in Parkinson’s disease and related neurodegenerative 
disorders. By using solution and solid-state NMR techniques in conjunction with other structural 
methods, we identified the fundamental characteristics that enable toxic α-synuclein oligomers 
to perturb biological membranes and disrupt cellular function; these include a highly lipophilic 
element that promotes strong membrane interactions and a structured region that inserts into lipid 
bilayers and disrupts their integrity. In support of these conclusions, mutations that target the 
region that promotes strong membrane interactions by α-synuclein oligomers suppressed their 
toxicity in neuroblastoma cells and in primary cortical neurons. 
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The aggregation of α-synuclein (αS) into amyloid fibrils within Lewy bodies is associated with 
Parkinson’s disease (PD) and a range of other debilitating neurodegenerative disorders (1-9). The 
primary pathogenic agents in these conditions are thought to be the oligomeric species populated 
in the self-assembly of αS, particularly through their aberrant interactions with biological 
membranes (10-16). Here we investigated two types of stabilized αS oligomers with significantly 
different toxicities (17, 18), which we designated as type-A* and type-B*. Their Förster 
resonance energy transfer (FRET) signatures (Fig. 1A), as well as other structural and biological 
properties (Fig. 1), closely matched those of the previously identified transient forms of non-
toxic (type A) and toxic (type B) αS oligomers (19). 
The two oligomeric forms of αS had similar sizes and morphologies (Fig. 1B-C), yet 
exhibited very different abilities to disrupt lipid bilayers. When incubated in vitro with small 
unilamellar vesicles (SUVs), type-A* oligomers induced only a marginal release of encapsulated 
calcein molecules, comparable to that induced by αS monomers and mature fibrils (Fig. 1D). In 
contrast, type-B* oligomers induced over ten times more calcein release, indicating that these 
oligomers generate considerable disruption of acidic lipid bilayers (Fig. 1D). We observed 
similar loss of membrane integrity in vivo upon incubation of type-B* αS oligomers with human 
neuroblastoma SH-SY5Y cells and rat primary cortical neurons, and only marginal effects upon 
incubation with type-A* oligomers, monomers and mature fibrils of αS (Fig. 1E, G). 
The significant disruption of synthetic and cellular membranes by type-B* αS oligomers, 
but not type-A* species, was strongly correlated with their ability to generate cellular toxicity. 
Thus type-B* αS oligomers, but not monomers, type-A* oligomers and αS fibrils, induced 
substantial increases of intracellular reactive oxygen species (ROS, Fig. S1A) and reduced the 
mitochondrial activity in neuronal cells (MTT, Fig. 1F). The cellular damage that type-B* αS 
oligomers induced in this manner reproduces a variety of patho-physiological effects observed in 
neuronal models of PD obtained by inducing pluripotent stem cell-derived neurons from a 
patient with triplication of the αS gene (20-22). 
 To probe the structural properties of the two types of αS oligomers, we used solid-state 
NMR (ssNMR) spectroscopy. Correlations between carbon atoms of residues located in rigid 
regions of the oligomers were detected using 13C-13C dipolar-assisted rotational resonance 
(DARR) correlation spectra, measured using magic angle spinning (MAS). 13C-13C-DARR 
spectra of type-A* and type-B* oligomers revealed fundamental differences in the structural 
nature of the two species (Fig. 2A), with a significant content of β-sheet identified in the rigid 
regions of the type-B* oligomers and negligible secondary structure content associated with the 
rigid regions of type-A* oligomers (Fig. 2A and S2). The assignment of the 13C-13C-DARR peaks 
was performed using an approach (23-25) that combines information from solution-state 
chemical exchange saturation transfer (23, 26, 27) (CEST, see Methods and Fig. S3) with known 
assignments of fibrillar (5) and monomeric (25) states of αS. This approach revealed that the 
resonances in the 13C-13C-DARR spectra of the two types of oligomers belong to specific regions 
spanning residues 3-36 and 70-88 in type-A* and type-B* species, respectively (Table S1). 
Highly mobile regions of the two forms of αS oligomers were detected using INEPT 
measurements in MAS ssNMR (Fig. 2B). Both types of oligomers contained a large number of 
highly mobile residues (45 in type-A* and 67 in type-B*, Table S1), whose resonances 
overlapped with those in the 1H-13C-HSQC spectra of disordered monomeric αS in solution (Fig. 
S4). Although both oligomeric species possessed a flexible C-terminal region (43 and 40 highly 
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mobile C-terminal residues for type-A* and type-B*, respectively), the N-terminal region of αS 
was highly dynamic only in the type-B* oligomers (0 and 26 highly mobile N-terminal residues 
for type-A* and type-B*, respectively). Furthermore, the mobile regions of the type-A* αS 
oligomers also included residues from the NAC region (Fig 2B), a finding consistent with the 
low FRET efficiency observed for the type-A* relative to the type-B* oligomers when the 
fluorophores were attached to residue 90, itself located in the NAC region (Fig. 1A). 
The ssNMR characterization of the two types of αS oligomers was supported by Fourier 
transform infrared (FT-IR) measurements (Fig. S5), showing signals characteristic of both 
random-coil and β-sheet structure in the case of the type-B* αS oligomers, but indicating a 
predominantly unstructured conformation for the type-A* species. Further indication of the 
association with the core of the oligomers in type-A* and type-B* species was provided by CEST 
experiments  (Fig. S3). Type-A* oligomers revealed extensive saturation in the 40 N-terminal 
residues of the protein, indicating a significant degree of association of this region with the core 
of the oligomers. For type-B* oligomers, CEST experiments showed no saturation associated 
with either the N- or C- terminal regions of the protein or with residues of three of the four major 
hydrophobic segments of the αS sequence (residues 36-41, 47-56, 88-95), in contrast to the 
significant saturation observed for the hydrophobic segment 70-79. The identification of highly 
dynamic regions in the two types of αS oligomers was consistent with a dot blot analysis carried 
out using a primary antibody that bind the N-terminal region of αS. This indicated that the N-
terminal region is more accessible in type-B* than in type-A* species (Fig. S6). In contrast, dot 
blot analysis carried out using a primary antibody targeting the C-terminal region of αS indicated 
that the C-terminus is accessible to a similar extent in both types of oligomers (Fig. S6). 
We next probed the interaction of the two types of αS oligomers with SUVs composed of 
DOPE:DOPS:DOPC lipids in a ratio of 5:3:2 (see Methods), which are good mimics of synaptic 
vesicles for composition and physical properties (24, 25). Fluorescence correlation spectroscopy 
(FCS) in combination with confocal microscopy showed that both types of oligomers bind the 
SUVs with high affinity, with the type-B* oligomers binding more strongly relative to the 
type-A* species (Fig. 3A and S7). Type-B* αS oligomers also colocalized with the plasma 
membrane of primary cortical neurons (Fig. 3B).  
To characterize the levels of membrane insertion of the two types of αS oligomers, we 
carried out paramagnetic relaxation enhancement (PRE) experiments using MAS ssNMR, in 
which small quantities of lipid molecules labeled with a paramagnetic center (PC) were 
incorporated into the bilayers (24, 25). When the PC was located in the hydrophilic head groups 
of the lipid molecules (see Methods), selective quenching of a number of 13C-13C-DARR 
resonances was observed in the spectra of both types of αS oligomers (Fig. S8). This indicates in 
both cases strong interactions with the membrane surface. In contrast, when the PC was 
positioned within the interior of the lipid bilayer, enhanced relaxation of 13C-13C-DARR 
resonances was observed only for the type-B* oligomers (Fig. 3C); this suggests that type-B* 
oligomers can insert into the hydrophobic interior of the lipid bilayer while the type-A* 
oligomers remain bound exclusively to the membrane surface (Fig. 3E-F). In addition, the 
1H-13C-INEPT spectra of the type-B* oligomers showed peak broadening only in PRE 
experiments performed when the paramagnetic center was located in the lipid head groups (Fig. 
S9); this suggests that dynamic regions of type-B* oligomers do not insert in the hydrophobic 
interior of the lipid bilayer. 
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To characterize the structural nature of the regions of αS that are tightly bound to the 
lipid bilayers in the two types of oligomers, we measured 13C-13C-DARR spectra at -19 °C (Fig. 
3D). This condition enhances the protein signals at the interface with this type of acidic lipid 
membrane (24, 25). In the case of the type-A* oligomers, we observed an additional set of peaks 
whose resonances are characteristic of lysine residues, which are abundant in the region 1-97 of 
the αS sequence. The broad linewidths of these resonances, however, indicated the absence of a 
defined structural motif of type-A* oligomers that is tightly bound to the membrane. In contrast, 
for the type-B* species we observed a set of additional resonances that closely matched those of 
the N-terminal 25 residues of monomeric αS bound to SUVs in an amphipathic α-helical 
conformation (12, 25, 28). Thus, the N-terminal region in the toxic oligomers is involved in 
promoting strong membrane interactions. 
 We next examined the effects that mutations in the N-terminal region of αS exert on the 
ability of type-B* oligomers to disrupt biological membranes and induce cellular toxicity. The 
A30P αS variant (αSA30P) is associated with an early onset form of PD and reduces the 
membrane affinity of the N-terminal region of αS (24). We also examined a truncated form of 
the protein lacking residues 2-9  (αSΔ2-9), a key region involved in anchoring the N-terminal 
region of αS to lipid membranes (25, 29).  In vitro measurements of calcein release from POPS 
SUVs showed intermediate and negligible levels of membrane disruption by type-B* oligomers 
formed from αSA30P and αSΔ2-9, respectively, compared to the effects of wild type αS (αSWT) 
type-B* oligomers (Fig. S10A). Similar trends were observed in the disruption of cellular 
membranes by these species (Fig. S10B) and in their colocalization with the plasma membrane 
(Fig. S10D-E). The partial and a total impairment of the binding and disruption of cellular 
membranes by type-B* oligomers of αSA30P and αSΔ2-9, respectively, correlated highly with the 
levels of cellular toxicity generated by these species (MTT in Fig. S10C and ROS in Fig. S1B). 
 In conclusion, here we identified two structural elements that determine the ability of 
toxic αS oligomers to generate permeability of biological membranes (Figs. 3F, S11). In primary 
neurons and astrocytes this leads to an increase in the levels of basal intracellular Ca2+ and of 
ROS, and a consequent loss of cellular viability (20, 21). The first structural element is an 
exposed highly lipophilic region of the protein in the oligomers that promotes strong interactions 
with the membrane surface. The second is a rigid oligomeric core that is rich in β-sheet structure 
and is able to insert into the lipid bilayer and disrupt the membrane integrity. These conclusions 
are strongly supported by the introduction of specific mutations that partially (A30P) or 
completely (Δ2-9) suppress the membrane affinity of the N-terminal sequence of the protein. 
This suggests that the ability of the accessible N-terminal region of αS to bind strongly to lipid 
bilayers is a vital step in enabling oligomers to disrupt cellular membranes and consequently to 
induce neuronal toxicity.  
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Figure 1. Properties of the two types of αS oligomers. (A) Intermolecular FRET efficiencies 
from measurements of type-A* (orange) and type-B* (green) αS oligomers. (B) Images of the 
type-A* and type-B* samples of αS oligomers probed by AFM (scale bar 200 nm). (C) 
Sedimentation coefficients of the type-A* (orange) and the type-B* (green) oligomers measured 
using AU. (D) In vitro calcein release (%) from POPS SUVs (see Methods). (E-F) Intracellular 
calcein-induced fluorescence (E) and mitochondrial activity monitored by the reduction of MTT 
(F) measured on human neuroblastoma SH-SY5Y cells (filled bars) and rat primary cortical 
neurons (striped bars) upon incubation with the various αS species. The data in panels D-F report 
the mean values ± standard deviations (see table S2 for P values). (G) Representative confocal 
scanning microscopy images of SH-SY5Y cells (scale bar 30 µm), showing intracellular calcein-




Figure 2. MAS ssNMR spectra of αS oligomers. (A) 13C-13C DARR correlation spectra 
(aliphatic regions) of type-A* and type-B* αS oligomers (left and right panels, respectively). (B) 
1H-13C correlations via INEPT transfer. The labels ca, cb, cg, cd and ce indicate Cα, Cβ, Cγ, Cδ 
and Cε atoms, respectively. The regions of the protein sequence detected in the spectra are 




Figure 3. Interactions of αS oligomers with lipid bilayers. (A) Diffusion times, τD, from FCS 
experiments of type-A* and type-B* αS oligomers in the presence of variable quantities of SUVs 
composed of DOPE:DOPS:DOPC. τD values and errors are derived from the fitting of the 
autocorrelation function (see Methods and Fig. S7).  (B) Representative confocal scanning 
microscope images of basal, median, and apical planes and their combination (fourth column) of 
primary cortical neurons upon incubation of 15 min with type-B* αS oligomers. Red and green 
fluorescence indicates the cell membrane and the αS oligomers, respectively. Lower panels 
correspond to magnifications of the sections indicated with a white square in the upper panels 
(C) PRE effects measured using MAS ssNMR for type-A* (left) and type-B* (right) αS 
oligomers using SUVs with a paramagnetic center at the position of carbon 16 of the lipid chain. 
13C-13C-DARR spectra measured in the presence and absence of the paramagnetic labeled lipids 
are shown in blue and red, respectively. (D) 13C-13C-DARR spectra of isolated type-A* (left) and 
type-B* (right) αS oligomers (red) compared with spectra measured at -19 °C in the presence of 
DOPE:DOPS:DOPC SUVs (green) and of monomeric αS bound to the same type of vesicles 
(24) (black contour lines). The arrows identify the signals of residues in the αS oligomers arising 
from the membrane-bound protein regions. In the case of type-B* αS oligomers these regions 
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were assigned from a previous study of the monomeric state of αS bound to SUVs (24). (E-F) 
Schematic representation of the binding of type-A* and type-B* with biological membranes. (E) 
Type-A* (left) are mainly disordered and bind exclusively to the membrane surface. (F) Type-B* 
αS oligomers feature both structured (red) and disordered (grey) regions, and bind the surfaces of 
the lipid bilayers via the N-terminal regions fold into amphipathic α-helices (blue) upon 
membrane binding. The rigid regions of type-B* αS oligomers, which are rich in β-sheet 
structure, insert into the lipid bilayers thereby disrupting their integrity. 
